Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Market price (% of par)
-
120.74%
-
Total 13F principal
-
$198,153,834
-
Principal change
-
+$21,503,900
-
Total reported market value
-
$243,379,250
-
Number of holders
-
19
-
Value change
-
+$25,811,330
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2021
As of 30 Sep 2021,
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$198,153,834
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, UBS ASSET MANAGEMENT AMERICAS INC, LAZARD ASSET MANAGEMENT LLC, CALAMOS ADVISORS LLC, CNH PARTNERS LLC, PUTNAM INVESTMENTS LLC, Polar Asset Management Partners Inc., Linden Advisors LP, and DEUTSCHE BANK AG\.
This page lists
19
institutional bondholders reporting positions
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.